Russian Health Ministry Authorises Clinical Trials of EpiVacCorona-N Vaccine

Apr 9, 2021 | EARNINGS

MOSCOW (Sputnik) – The Russian Health Ministry has authorized phase 1 and 2 clinical trials of EpiVacCorona-N, one more coronavirus vaccine developed by the Vector research center, according to the ministry’s register.

Read More

Pin It on Pinterest